Safety and Handling Instructions
Access to drugs with a potential for abuse such as Hydromorphone Hydrochloride Injection presents an occupational hazard for addiction in the health care industry. Routine procedures for handling controlled substances developed to protect the public may not be adequate to protect health care workers. Implementation of more effective accounting procedures and measures to restrict access to drugs of this class (appropriate to the practice setting) may minimize the risk of self-administration by health care providers.
How Supplied
Hydromorphone Hydrochloride Injection is supplied as a sterile solution in single‑dose NexJectTM prefilled syringes for intravenous, intramuscular, and subcutaneous administration, and available as follows:
| Unit of Sale | Concentration (per total volume) |
|---|---|
NDC 0409-1805-01 Clamshell of 10 0.5 mL fill in 1.5 mL NexJect™ Single-dose Prefilled Syringe with Luer Lock | 0.25 mg/0.5 mL |
NDC 0409-4264-01 | 0.5 mg/0.5 mL |
NDC 0409-1283-37 | 1 mg/mL |
NDC 0409-1312-36 | 2 mg/mL |
NDC 0409-1380-01 | 4 mg/mL |
Safety and Handling Instructions
Access to drugs with a potential for abuse such as Hydromorphone Hydrochloride Injection presents an occupational hazard for addiction in the health care industry. Routine procedures for handling controlled substances developed to protect the public may not be adequate to protect health care workers. Implementation of more effective accounting procedures and measures to restrict access to drugs of this class (appropriate to the practice setting) may minimize the risk of self-administration by health care providers.
How Supplied
Hydromorphone Hydrochloride Injection is supplied as a sterile solution in single‑dose NexJectTM prefilled syringes for intravenous, intramuscular, and subcutaneous administration, and available as follows:
| Unit of Sale | Concentration (per total volume) |
|---|---|
NDC 0409-1805-01 Clamshell of 10 0.5 mL fill in 1.5 mL NexJect™ Single-dose Prefilled Syringe with Luer Lock | 0.25 mg/0.5 mL |
NDC 0409-4264-01 | 0.5 mg/0.5 mL |
NDC 0409-1283-37 | 1 mg/mL |
NDC 0409-1312-36 | 2 mg/mL |
NDC 0409-1380-01 | 4 mg/mL |
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.